Lingling Zhao

8PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 18, 2026
CRTAC1 inhibits progression of lung adenocarcinoma by suppressing integrin/FAK signaling.

Yu Liu, Yuanyuan Chang, Haiying Li

|Nov 22, 2025
Arsenic promotes ROS-mediated malignant transformation of bronchial epithelial cells by specifically downregulating TXNL1 expression.

Lingling Zhao, Xueli Jiao, Hongyan Li

|Jul 28, 2025
ACADS Suppresses Proliferation of Colorectal Cancer Cells via ROS-Triggered Autophagy and Degradation of CDK2.

Yimeng Ma, Meiting Tong, Baiwang Zhu

|Aug 26, 2023
CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression.

Zihui Jin, Lingling Zhao, Yixin Chang

|Mar 07, 2023
C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis.

Shirui Huang, Jizhen Li, Shuang Wu

|Oct 18, 2022
Downregulation of TEX11 promotes S-Phase progression and proliferation in colorectal cancer cells through the FOXO3a/COP1/c-Jun/p21 axis.

Xiaodong Zhang, Fangyu Hu, Baiwang Zhu

Pageof 2

Frequent Collaborators

4 joint publications

Haishan Huang

3 joint publications

Chuanshu Huang

3 joint publications

Qipeng Xie

2 joint publications

Hongyan Li